We are pleased to share that Dr Yann Chong Tan, Chief Executive Officer and co-founder of Nuevocor, will be delivering an oral presentation titled “NVC-001 – an AAV gene therapy for LMNA-related dilated cardiomyopathy” at the European Society for Gene and Cell Therapy 31st Annual Congress on 22 – 25 October 2024, La Nuvola, Rome.  The presentation is scheduled on 24 October 2024 during Session 7c: Cardio and Muscular between 9.00am to 11.00am.

​

​

 

​